← Open Payments lookup

WILLIAM MORRIS: Open Payments

NPI 1720147150 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,217 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $1,217

Long term medical supply or device loan: $997Food & beverage: $220
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation12$1,050
Janssen Biotech, Inc.2$52
PharmaEssentia USA Corporation1$31
Daiichi Sankyo Inc.1$28
Genmab U.S., Inc.1$22
Incyte Corporation1$17
AstraZeneca Pharmaceuticals LP1$16

Products named: KISQALI, LEQVIO, BESREMI, TECVAYLI, Enhertu, TREMFYA, Epkinly, PLUVICTO.

Industry payments across CA — which companies pay providers there.